Navigation Links
Nationally Recognized Glenveigh Medical Announces Orphan Drug Designation for Treatment for Severe Preeclampsia and Eclampsia
Date:2/14/2012

CHATTANOOGA, Tenn., Feb. 14, 2012 /PRNewswire/ -- Glenveigh Medical  announced today that the U.S. Food and Drug Administration (FDA) has granted its request for orphan drug designation for a potential new therapy to treat severe preeclampsia and eclampsia. The compound, digoxin immune fab (ovine), is an existing biologic approved for use in cases of digoxin toxicity. Glenveigh, a nationally renowned life science company, has extensive clinical and in vitro evidence to support continued development of this late-stage opportunity. Preeclampsia occurs in 5-8% of pregnancies in the U.S., and these severe forms are leading causes of maternal and perinatal mortality globally.

"This is a tremendous milestone for our company," stated C. David Adair, M.D., Founder, Chairman, and Chief Scientific Officer of Glenveigh. "As a physician and scientist, I have personally seen the devastation these conditions have caused to both moms and babies.  Our program, which includes two successful Phase II studies, offers hope to patients that there will be a treatment for severe preeclampsia in the near future."

Preeclampsia is a condition in pregnant women that is characterized by high blood pressure and excess protein in the urine in the second and third trimesters of pregnancy. Severe preeclampsia and eclampsia represent the most advanced stages of the disease in which pregnant women can suffer from seizures and organ failure.

"In addition to our patents, orphan designation gives Glenveigh at least 7 years of marketing exclusivity," noted Rick Proctor, President and CEO. "We are delighted that the FDA granted orphan drug designation which gives innovators added incentives to pursue treatments for smaller patient populations."

Eleni Tsigas, Executive Director of the Preeclampsia Foundation, added, "Severe preeclampsia can be life-threatening to mother and baby.  Effective interventions for this serious disorder of pregnancy are lacking. We are thrilled that this designation can better enable further research and development that may lead to a potential therapy."

ABOUT GLENVEIGH MEDICAL | www.glenveigh.com  

Glenveigh Medical is a life science and technology based company focused on advancing the practice of obstetrics. Founded in 2004 by a maternal-fetal medicine specialist, Glenveigh prides itself on bringing innovative solutions to the obstetrics industry, relying upon its scientific and medical advisors to provide guidance on market opportunities that will significantly benefit patients in need. Glenveigh's marketed products include the following medical devices: ebb® (post partum hemorrhage), jetty® (vaginal repairs), and Beacon™ (wireless fetal monitor). Glenveigh is based in Chattanooga, Tennessee.


'/>"/>
SOURCE Glenveigh Medical
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Leading Chemical Weapons Preparedness Companies Announce Partnership to Deploy Break-through Diagnostic Test Internationally
2. Masimo Introduces Pronto-7™ Internationally and Lifts Voluntary Recall
3. Medela Announces 2011 Breastfeeding Hall of Excellence Inductees to Nationally Recognize Exceptional Breastfeeding Advocates
4. Instead of Preventing Infections, Silver Coated Needleless IV Connectors May Actually Cause Them, a Nationally-Recognized Expert Tells National Conference on Cancer Nursing Research
5. Reportlinker Adds Germany Pharmaceutical Market Overview - New pricing rules set to negatively impact drug sales both domestically and internationally
6. Medical Simulation Corporation Signs Agreement With a Nationally Ranked Hospital
7. CORD:USE Cord Blood Bank Featured Internationally on CNN en Espanol
8. Internationally Renowned Bariatric and Laparoscopic Surgeons To Meet in San Diego
9. Lilly Recognized as a Top Company for Executive Women
10. The Lanier Law Firms Dana Taschner Recognized Among Southern Californias Top Lawyers
11. nContacts Corporate Website Recognized as Best in Class Medical Site by Interactive Media Council - www.ncontactinc.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)...  Eli Lilly and Company (NYSE: LLY ) today ... disodium) vitamin regimen patent would not presently be infringed by ... , Italy and ... with dextrose solution.  --> ... Appeal held that Lilly,s patent would be indirectly infringed by ...
(Date:2/12/2016)... LOUISVILLE, Ky. , Feb. 12, 2016 ... it has completed a $47.1 million Series ... investors Cormorant Asset Management, Hillhouse Capital Group ... investors Morningside Venture Investments, AJU IB Investment, ... will be used to further advance clinical ...
(Date:2/11/2016)... 2016 The primary goal of this research ... on the usage of liquid biopsy. Key information the ... - Timeframe of liquid biopsy adoption amidst future users ... organization type - Sample inflow to conduct liquid biopsy ... serum, and so on. - Correlation analysis of sample ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... Coco Libre, the maker of ... Carpet Events LA GRAMMY’s Style Lounge Event. Coco Libre will offer musicians and celebrities ... before the big event. The invitation-only gifting suite, held this year at the W ...
(Date:2/12/2016)... ... February 12, 2016 , ... Every winter, someone is killed, injured ... West Penn Burn Center, part of the Allegheny Health Network, has partnered ... you the “Space Heaters Need Space” campaign. , “Space Heaters Need Space” ...
(Date:2/12/2016)... ... February 12, 2016 , ... Vail knee specialist Robert LaPrade, MD, PhD ... 2016 . The list consists of physicians establishing, leading and partnering with ambulatory surgery ... , An Ambulatory Surgery Center, also known as an ASC, is a modern health ...
(Date:2/12/2016)... ... ... Miami Dental Specialists is excited to bring patients the choice of ceramic, ... Dental Specialists will offer the non-metal implants as a safe, holistic and hygienic approach ... the dental implant manufacturer, Straumann, to bring this cutting-edge technology to Miami. ...
(Date:2/12/2016)... ... February 12, 2016 , ... Nearly every ... promote eye health. These articles generally list between five and 15 foods that ... Kleyne endorses every one of these lists and believes that nutritious eye healthy ...
Breaking Medicine News(10 mins):